US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 3.570
  • +0.070+2.00%
Close Sep 27 16:00 ET
  • 3.570
  • 0.0000.00%
Post 16:20 ET
406.54MMarket Cap-2100P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.294M--
--2024/Q3-- / 1.445M--
--2024/Q26.772M / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.294M--
--2024/Q3-- / 1.445M--
--2024/Q26.772M / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--

Unlock Free Earnings Estimates

Fate Therapeutics Earnings Reports

  • Fate Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:14 ET

  • Fate Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 16:09 ET

  • Fate Therapeutics | 10-K: FY2023 Annual Report

    Feb 26 16:18 ET

  • Fate Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data